Biotech Financing Deal Closes

TroyGould represented Lion Biotechnologies, Inc. (OTC Markets: LBIO)  in connection with a $23.3 million private financing that closed November 5, 2013.

Roth Capital Partners, LLC, served as the lead placement agent, with Highline Research Advisors LLC a Division of Agincourt, LTD acting as the co-placement agent.
TroyGould attorneys for the transaction included member Istvan Benko and associate Dietrick Miller.